Characteristics | No of patient | % |
---|---|---|
Age, median = 63.4 (36.4-74.1) | Â | Â |
   30- 60 | 10 | 38.5% |
   > 60 | 16 | 61.5% |
Sex (n = 26) | Â | Â |
   Male | 22 | 84.6% |
   Female | 4 | 12.5% |
Stage at diagnosis (n = 26) | Â | Â |
   Stage IB | 3 | 11.5% |
   Stage II | 6 | 23.1% |
   Stage III | 7 | 26.9% |
   Stage IV | 10 | 38.5% |
Endoscopic finding (n = 23) | Â | Â |
   Borrmann type I | 2 | 8.7% |
   Borrmann type II | 5 | 21.7% |
   Borrmann type III | 11 | 47.8% |
   Borrmann type IV | 1 | 4.3% |
   EGC†| 4 | 17.4% |
Location (n = 25) | Â | Â |
   Upper-third | 2 | 8.0% |
   Middle-third | 5 | 20.0% |
   Lower-third | 16 | 64.0% |
   Whole stomach | 2 | 8.0% |
Immunohitstochemical staining (n = 26) | Â | Â |
   AFP (positive/negative/‡NA) | 15/4/7 |  |
   Anti-hepatocyte (positive/negative/‡NA) | 4/4/18 |  |
   Anti-chymotrypsin (positive/negative/‡NA) | 1/1/24 |  |
Serum AFP (n = 26) | Â | Â |
   Elevated (median, range) | 7 ( 208 ng/ml, 5-4,750,000 ng/ml) |  |
   Normal | 4 |  |
   ‡NA | 15 |  |